NCT04299633COMPLETEDanonymous

A Phase 1, Three-Part, Open-Label Study in Healthy Adult Subjects to Assess the Effect of Phosphate Binders on the Pharmacokinetics of a Single Dose of Vadadustat

Sponsor

Source record

Akebia Therapeutics

Phase

Source record

Phase 1

Modality

AI-normalized

small molecule

Target

AI-normalized

Vadadustat

Indication / condition

AI-normalized

Healthy Volunteers

Intervention

Source record

Vadadustat, Sevelamer carbonate, Calcium acetate, Auryxia®

Related intelligence directories

Indication directory: Healthy Volunteers Modality directory: small molecule Target directory: Vadadustat

Source & freshness

Source record

NCT ID

NCT04299633

Original source

ClinicalTrials.gov

Source last updated

Oct 08, 2020

Ingested at

May 31, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record

View original source fields

NCT ID

NCT04299633

Title

A Phase 1, Three-Part, Open-Label Study in Healthy Adult Subjects to Assess the Effect of Phosphate Binders on the Pharmacokinetics of a Single Dose of Vadadustat

Sponsor

Akebia Therapeutics

Status

COMPLETED

Phase

Phase 1

Condition raw

Healthy Volunteers

Condition normalized

Healthy Volunteers

Modality raw

Healthy Volunteers

Modality normalized

small molecule

Target raw

Vadadustat

Target normalized

Vadadustat

Interventions

Vadadustat, Sevelamer carbonate, Calcium acetate, Auryxia®

Public preview

Source record

This clinical trial, sponsored by Akebia Therapeutics, evaluated the pharmacokinetics of Vadadustat when administered with phosphate binders (sevelamer carbonate, calcium acetate, and Auryxia) in healthy adult subjects. The study aimed to understand potential drug interactions that could affect the efficacy and safety of Vadadustat.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Early access offer

Subscribe with code FOUNDERS5 for a 5-day premium trial.

Full protocol, outcomes, eligibility, contacts and results sections

Patent/IP landscape with verified records when available

Board-ready PDF export with source provenance

Save to folders and synthesize multiple assets in premium workspace

Create account

Create a free account first, then unlock a single report, buy credits or subscribe.

Investment-Ready Snapshot

A Phase 1, Three-Part, Open-Label Study in Healthy Adult Subjects to Assess the Effect of Phosphate Binders on the Pharmacokinetics of a Single Dose of Vadadustat

Source & freshness

Public preview

Create an account to unlock this report

A Phase 1, Three-Part, Open-Label Study in Healthy Adult Subjects to Assess the Effect of Phosphate Binders on the Pharmacokinetics of a Single Dose of Vadadustat

Investment-Ready Snapshot

Provenance

Protocol Description

Outcome Measures

Eligibility

Known Results And Readout Context

Patent And IP Landscape

Contacts